Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Scientific Reports|December 1, 2015
Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: a genome wide association studyChrissy h Roberts, Christopher S Franklin, Pateh Makalo, et al.
The New England Journal of Medicine|December 18, 2024
Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring VaccinationJean-Jacques Muyembe, Hongchao Pan, Richard Peto, et al.
BMJ Open|November 1, 2020
Health service needs and perspectives of remote forest communities in Papua New Guinea: study protocol for combined clinical and rapid anthropological assessments with parallel treatment of urgent casesJo Middleton, Mohammad Yazid Abdad, Emilie Beauchamp, et al.
Vaccines|August 29, 2024
Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the CongoEdward Man-Lik Choi, Kambale Kasonia, Hugo Kavunga-Membo, et al.
Science Immunology|November 11, 2018
Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1Lies Boelen, Bisrat Debebe, Marcos Silveira, et al.
Bone Marrow Transplantation|March 24, 2020
Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AMLWill P Bultitude, Jennifer Schellekens, Richard M Szydlo, et al.
BMC Medicine|November 7, 2024
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches)Conall H Watson, Pierre-Stéphane Gsell, Yper Hall, et al.
Pageof 8